Gyre Therapeutics, Inc. Common Stock
GYREGyre Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies targeting neurological and neurodegenerative disorders. Utilizing advanced drug delivery platforms, Gyre aims to address unmet medical needs through novel treatments that improve patient outcomes.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| January 12, 2023 | $0.24 | 2023-01-13 | 2023-01-05 |
| September 20, 2022 | $1.43 | 2022-09-21 | 2022-09-06 |
| August 19, 2015 | $0.57 | 2015-08-20 | 2015-08-14 |
Dividends Summary
- Gyre Therapeutics, Inc. Common Stock has issued 3 dividend payments over the past 8 years
- The most recent dividend was paid 1061 days ago, on January 12, 2023
- The highest dividend payed out to investors during this period was $1.43 per share
- The average dividend paid during this period was $0.75 per share.
Company News
Gyre Therapeutics reported Q3 2025 net income of $5.9 million, with quarterly revenue of $30.6 million, up 20% year-over-year. The company revised full-year revenue guidance to $115-118 million due to delayed product rollouts and procurement uncertainties.
Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. Fastenal reported first-quarter FY24 sales growth of 1.9% Y/Y to $1.895 billion, missing the consensus of $1.914 billion. The company's first-quarter EPS was 52 cents, missing the consensus of 53 cents...
